News

LGT Private Debt provides debt facilities to support Ambienta’s acquisition of Agronova Biotech

24 July 2025

LGT Private Debt has arranged debt facilities to support private equity investor Ambienta’s acquisition of Agronova Biotech, one of the leading global biological crop solutions platforms based in Spain. This marks LGT Private Debt’s third transaction in Spain in the last 14 months, following its investments in HT Médica and HTBA.

Headquartered in Murcia, Spain, Agronova Biotech manufactures biological agricultural input products for crop nutrition and protection with a 50-year track record. The company services the full crop lifecycle, including nutrition, biofertilizers, biostimulants, and biocontrols. Agronova Biotech offers its extensive product portfolio in more than 50 countries across Europe and the Americas.

Kevin Abrial, Partner at LGT Private Debt, said: “We are pleased to partner with Ambienta again and look forward to supporting Agronova Biotech in its next phase of growth. We believe the company is well positioned to continue building its strong position in the biological agri-inputs market, driven by the accelerating shift to sustainable agricultural practices.”

Private debt is one of LGT Capital Partners’ areas of expertise in the field of private markets. The team has an average of 13 years of industry experience and is based in Paris, London and Frankfurt am Main. It has invested more than EUR 6.0 billion since 2005. As a specialist in the European private debt market, it arranged the first unitranche transaction in Europe in 2007. LGT Private Debt has been investing in Spain since 2015.

private_debt_transaction_-_agronova_biotech
Content type of this page